Recruiting Bipolar Disorder Studies in Anaheim
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
This is a multicenter, randomized, double-blind, placebo-controlled study in pediatric patients who are experiencing major depressive episodes (MDEs) associated with a primary diagnosis of bipolar I o...
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United States. The treatment of the depressive episodes of ...
Study of Lumateperone in the Treatment of Patients With Bipolar Mania
This is a multicenter, randomized, double-blind, placebo-controlled, study in the acute treatment of patients with a diagnosis of bipolar I disorder with manic episodes or manic episodes with mixed fe...
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
This is a phase 3, open-label extension study to assess the long-term safety of KarXT for the treatment of mania or mania with mixed features in Bipolar-I disorder (BP-I) The primary objective of the...
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
The purpose of this study is to evaluate the efficacy and safety of KarXT for the treatment of manic episodes in Bipolar-I Disorder...
Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II Disorder
Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population in the United States. This study will assess how safe and effective ABBV-932 is in treating participant...
About Bipolar Disorder Clinical Trials in Anaheim
Bipolar disorder is a mental health condition marked by extreme mood swings including emotional highs (mania or hypomania) and lows (depression). It affects about 2.8% of adults in the U.S. Treatment typically involves mood stabilizers, antipsychotics, and psychotherapy.
There are currently 6 bipolar disorder clinical trials recruiting participants in Anaheim, CA. These studies are seeking a combined 1,848 participants. Research is being sponsored by Intra-Cellular Therapies, Inc., AbbVie, Bristol-Myers Squibb. Clinical trial participation is free and participants receive study-related medical care at no cost.
Bipolar Disorder Clinical Trials in Anaheim — FAQ
Are there bipolar disorder clinical trials in Anaheim?
Yes, there are 6 bipolar disorder clinical trials currently recruiting in Anaheim, CA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Anaheim?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Anaheim research site will contact you about next steps.
Are clinical trials in Anaheim free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Anaheim studies also compensate for your time and travel.
What bipolar disorder treatments are being tested?
The 6 active trials in Anaheim are testing new therapies including novel drugs, biologics, and treatment approaches for bipolar disorder.
Data updated March 2, 2026 from ClinicalTrials.gov